Economic Evaluation of Nivolumab Plus Ipilimumab Combination as First-Line Treatment for Patients with Advanced Melanoma in Canada.

Name: Economic Evaluation of Nivolumab Plus Ipilimumab Combination as First-Line Treatment for Patients with Advanced Melanoma in Canada.
Author: Quon, Peter L

Economic Evaluation of Nivolumab Plus Ipilimumab Combination as First-Line Treatment for Patients with Advanced Melanoma in Canada. — المؤلف: Quon, Peter L — PharmacoEconomics - open Sep 2019

المؤلف: Quon, Peter L
النشر: PharmacoEconomics - open Sep 2019
الوصف: 321-331 p.